Q1 2021 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-04-28 | ||||||
REV |
Q4 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.040 | -0.180 | -0.1400 | ||||
REV | 13.430M | 13.774M | 344.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
ALIM | Alimera Sciences | 7.95 | -1.04 | -11.57% | 45.5M |
You can purchase shares of Alimera Sciences (NASDAQ: ALIM) through any online brokerage.
Other companies in Alimera Sciences’s space includes: Opiant Pharmaceuticals (NASDAQ:OPNT), Baudax Bio (NASDAQ:BXRX) and Cumberland (NASDAQ:CPIX).
The latest price target for Alimera Sciences (NASDAQ: ALIM) was reported by H.C. Wainwright on 2020-04-14. The analyst firm set a price target for 14.00 expecting ALIM to rise to within 12 months (a possible 76.10% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Alimera Sciences (NASDAQ: ALIM) is $7.95 last updated Thu Feb 25 2021 21:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Alimera Sciences.
There is no upcoming split for Alimera Sciences.